Company Active LTD

Company profile

Recourse Ai LTD.

Re:course - Reimagine clinician potential, transform patient care

Re:course is the leading conversational AI learning & assessment platform for healthcare professionals. Engage in natural free-flowing conversation with AI-powered digital avatars to replicate real human interactions.

CRN
11269312
Founded
2018
Age
8

Overview

Legal name
RECOURSE AI LTD.
Region
Unknown
Registered address
RECOURSE AI
8 HEWITT STREET
MANCHESTER
ENGLAND
M15 4GB
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
15

Company events

Reference milestones and recent Companies House filing stream events.

8 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

14 Jul
2026

Gazette Notice Compulsory

Gazette

GAZ1 | Transaction MzUyOTMzNTAyNWFkaXF6a2N4 | Paper/PDF filed

Published 08 Jul 2026 02:44

04 Apr
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

21 Mar
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

18 Nov
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ0MzAzOTIxOWFkaXF6a2N4 | Paper/PDF filed

Published 19 Nov 2024 10:39

13 Nov
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MzAzOTIxOGFkaXF6a2N4 | Paper/PDF filed

Published 14 Nov 2024 09:18

22 Mar
2018

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2020
Funded years
2020
Age at first award
1 years

Projects

2020 Collaborative R&D Lead participant

Intelligent Medical Case Storage and Analytics Platform for Healthcare Training

1 Nov 2020 to 31 Jul 2021

Awarded
£85,092
Total cost £85,092

"It is likely that most people will experience at least one diagnostic error in their lifetime, sometimes with devastating consequences" (Institute of Medicine, 2015), with UK-based studies indicate estimating that 1 in 10 patients admitted to hospital suffer harm (Vincent et al., 2001). Unnecessary tests and treatments have been reported to cost the NHS ...

2020 Feasibility Studies Lead participant

Design and development of COVID-19 Virtual Standardised Patients for medical training

1 Jul 2020 to 30 Sep 2020

Awarded
£47,969
Total cost £47,969

China have outlined healthcare simulation as an effective response in their hour of need, _"After identifying the need for training, simulation has become a powerful weapon fighting against the virus, as it can not only ensure patient safety but also provide a safe learning and training environment for HCWs to develop practical skills to deal with the COV...

2020 Collaborative R&D Lead participant

Design and development of a Virtual Standardised Patient platform for improving medical training

1 Jan 2020 to 30 Jun 2021

Awarded
£149,991
Total cost £299,982

.

Product types

Collaborative R&D Feasibility Studies